Microchimerism – What’s in a word?

Posted on | April 24, 2026 | No Comments

Mike Magee

According to some estimates, a medical student learns upwards of 15,000 new words during the four years of training. But the scope of the language challenge extends well beyond these tightly conscripted years since discoveries, and accompanying language to describe and label those new findings, accumulate throughout the entire span on one’s professional lifetime. And that was before AI which will spawn a world of new discoveries and terminology.

One word that has risen in prominence with the arrival of this new century is microchimerism.

“Microchimerism is the presence of cells from one individual in another genetically distinct individual.”

A 2019 review laid out the basics:

“Pregnancy is the main cause of natural microchimerism through transplacental bi-directional cell trafficking between mother and fetus.”
“Furthermore, it is now known that microchimerism persists decades later both in mother and in her progeny.”
“The consequences of pregnancy-related microchimerism are under active investigation.”

The most common cause of microchimerism is pregnancy. By 4 weeks of gestation fetal cells can be detected in the mother’s circulatory system even after stillbirth or miscarriage. The reverse is true as well. Maternal cells can be detected in newborns circulation and have been found embedded in baby’s skin, thymus, spleen, liver and thyroid.

The term first appeared in the medical literature in the 1970’s. It was intended to suggest both an unusual occurrence and an unlikely biologic mixture of living elements. “Chimera” is a mythological term associated with monstrous imagery – a creature composed of portions of multiple animals. In Greek mythology, the chimera breathes fire and possesses the body of a lion, a goat’s head arising from its back, and a snake’s head for a tail.

The description above of “cell trafficking” may seem a bit overwrought, but the modern day reality is that this phenomenon, and several other observations have triggered a radical reconsideration of the formerly rock-solid cornerstone of the field of Immunology – the capacity on a cellular and molecular level to distinguish “self” from “non-self.”

As one expert stated recently, “Numerous discoveries have focused attention on how immune responses are finely tuned by a range of contextual cues, including tissue signals, hygienist theory, molecular mimicry, symbiotic microbes, metabolic factors and epigenetic modifications… microchimeric cells in adults demonstrate that genetically foreign cells can be actively integrated into the host, challenging the simple assumption that ‘foreign’ equals unconditional attack… foreign elements might be tolerated (commensal bacteria, fetal cells, integrated viruses) or self-components might provoke aggression (autoimmunity, tumor immunity)…illustrating the remarkable plasticity of the immune system. The immune system is less a policeman patrolling a hard border than a manager of ongoing negotiations between host biology and environmental influences.”

On the leading edge of the field, “self” is no longer static, but “evolutionary” instead. In this brave new world, the vast collection of microorganisms that make up the microbiome are symbiotic, helpful, and actively evolving side by side with their “more human” cellular counterparts. Beyond the boundaries of a skin-deep innate immune system, the ecological determinants of health and illness are actively asking our systematic immune regulators to acknowledge, respond and adjust to a range of epigenetic determinants.

We’ve come a long way since Paul Ehrlich published his 1906 “General review of recent work in Immunity.” His publication at the time was a radical departure from philosopher John Locke’s 1690 “An Essay Concerning Human Understanding” exploring human memory and consciousness, reaching beyond the material boundaries of the human body. Biologic terms of human identity were now up for grabs.

Over the 20th century, the field grew side-by-side with modern understanding of infectious diseases, immunity, anaphylaxis, organ transplantation, rejection and more. The questions that were cued up, and largely addressed one by one, were probing – even disturbing.

“How does the body fight and remember certain pathogens?”
“What are the molecular complexes that mark ‘selfhood?’ Do all lifeforms possess similar molecular tags? Are mine different from your’s, from even a twin?”
“How is the system regulated so that it doesn’t over-react and attack itself as it appears to do with autoimmune diseases?”
“If the body is host to trillions of microbes, many essential for normal physiology, does the immune system categorize them as foreign? Are they included in the extended sense of self?”

As the 21st century dawned, there seemed to be more questions than answers. But most immunologists believe that our human immune systems share three important characteristics: specificity, memory, and tolerance. Experts agree that these elements provide “intellectual scaffolding for the notion that ‘normal’ immunity was based on recognizing foreign antigens while ignoring the self.”

In recent years, if anything, exploration outside accepted norms for Immunology have only grown. Microchimerism, microbiomes, molecular mimicry enabling destructive autoimmune diseases like MS, all suggest that “self” is a moving target with remarkably porous boundaries.

But the field of Immunology is expanding far and wide. Here are three examples:

Immunosenesence: The phenomenon of aging has attracted immunologists. “Immuno-senescence become evident after mid-life, as thymic involution restricts the output of naive T cells, and cumulative inflammatory signals, sometimes referred to as ‘inflammaging’, begin to erode the boundary that once reliably separated self from non-self. In advanced age, weaker pathogen defenses coexist with a paradoxical rise in auto-reactive phenomena, reflecting an overall decline in regulatory stringency.”
Immunotherapy: Therapeutics are now front and central in the field. One remarkable example of success, with 5-year survival rates exceeding 50%, is metastatic melanoma. An oncologist at Sloan Kettering explains that “Immunotherapy works by stimulating the immune system to identify and destroy melanoma cells. Melanoma cells can evade the immune response by exploiting certain proteins known as checkpoints. Blocking these immune defense cells allows a direct attack on the cancer cells.”
Neuro-immune Cross Talk: “A mutual expression of molecules from both domains (Immunology and Neurology) highlights a shared ‘cognitive’ capacity: the nervous and immune systems each interpret a vast array of molecular signals, be they hormonal, neurotransmitter, or pathogen-associated cues and generate responses that maintain organismal homeostasis. In effect, the immune system becomes akin to a sensory organ, attuned not solely to microbial invaders but also to internal physiological shifts, while the nervous system extends beyond classical neurotransmission to engage in immuno-modulatory functions.”

If “microchimerism” is the word of the decade, what word will come next? Here’s a prediction.

“Holobiont is defined as a biological system consisting of a host and its symbionts, which engage in continuous exchange of information and genetic material, leading to the development of a metabolome and hologenome that adapt and persist in response to environmental factors.”

HealthCommentary

Exploring Human Potential

Microchimerism – What’s in a word?

Comments